Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus with low-dose calcineurin inhibitor in lung transplant recipients with chronic kidney toxicity
2008-000102-36Phase 3Active
- Sponsor
- IRCCS San Matteo Foundation
- Start
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of everolimus in Renal Insufficiency (RI), sponsored by IRCCS San Matteo Foundation. Primary endpoint: Reduction in slope of renal function curve after 1 year. Started Feb 2008; status: active.
02
Drugs
everolimus
03
Conditions
Renal Insufficiency (RI)
Beyond the preview
Go deeper on 2008-000102-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000102-36.